News
HQF Preview | International Drug Safety Governance and China's Drug Regulatory Reform Release date： 2026-10-22 Source：CIIE
The parallel session on "International Drug Safety Governance and China's Drug Regulatory Reform" of the 9th HongQiao Forum will be held on the morning of November 6, 2026, at the Silk Road Hall in Hall 4.2 of the National Exhibition and Convention Center (Shanghai). The session will be jointly hosted by the National Medical Products Administration (NMPA) and the HongQiao Forum Secretariat.
The session has invited officials from the NMPA and the Shanghai Municipal Government to attend and deliver remarks. International guests, including Arieh Warshel, a Nobel laureate in Chemistry, and Paulin Basinga, Director for Africa at the Gates Foundation, will share their perspectives on the future of global pharmaceutical innovation and development. Officials from relevant departments and affiliated institutions of the NMPA will introduce China's latest regulations and policies on drugs, medical devices and cosmetics, and outline the NMPA's practices in further deepening regulatory reforms for drugs and medical devices and in promoting the high-quality development of the pharmaceutical industry. In addition, global executives from several multinational companies will share the current state of development and outlook for pharmaceutical, medical device and cosmetics companies in China.
The China International Import Expo Bureau (hereinafter referred to as the "CIIE Bureau") cites or reposts media reports for non-commercial purposes to facilitate information sharing. Such actions do not constitute an endorsement of the accuracy, authenticity, or legality of the original content, nor do they reflect the official stance of the CIIE Bureau. All copyrights and legal responsibilities for the reposted content remain with the original publishers and authors.
If any individual or entity believes that content shared on this website infringes their legitimate rights and interests, please promptly notify us in writing, providing detailed explanations, supporting documentation, and rationale. Upon receiving such materials, we will promptly remove or rectify the disputed content or take other appropriate measures.
Reposted or cited information may be time-sensitive. Users are advised to exercise independent judgment regarding the accuracy and completeness of the content. The CIIE Bureau shall not be liable for any direct, indirect, incidental, consequential, special, punitive, or exemplary damages arising from the use of or inability to use the information or links provided on this website.。
The CIIE Bureau respects intellectual property rights and is committed to delivering high-quality content services within a lawful and compliant framework.